Neonatal hepatic steatosis by disruption of the adenosine kinase gene.

Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature (2011) 4.85

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev (2011) 4.16

Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest (2008) 1.86

The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol (2007) 1.72

Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice. Gastroenterology (2014) 1.48

Inhibition of Adenosine Kinase Attenuates Acute Lung Injury. Crit Care Med (2016) 1.39

Adenosine signaling and function in glial cells. Cell Death Differ (2009) 1.39

TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase. Development (2009) 1.28

Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev (2013) 1.26

Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol (2007) 1.23

Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication. Proc Natl Acad Sci U S A (2012) 1.21

Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies. Epilepsy Res (2009) 1.17

Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. Am J Hum Genet (2011) 1.14

Adenosine dysfunction in epilepsy. Glia (2011) 1.14

Gene expression and biological processes influenced by deletion of Stat3 in pulmonary type II epithelial cells. BMC Genomics (2007) 1.10

Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Invest (2013) 1.09

Cell and gene therapies for refractory epilepsy. Curr Neuropharmacol (2007) 1.06

Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes (2011) 1.06

Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model. Nat Genet (2013) 1.04

Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Int J Mol Sci (2013) 1.04

Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol (2009) 1.03

Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology (2011) 1.02

Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics (2009) 0.98

Adenosine kinase as a target for therapeutic antisense strategies in epilepsy. Epilepsia (2011) 0.97

Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice. Neuron Glia Biol (2009) 0.96

Adenosine kinase determines the degree of brain injury after ischemic stroke in mice. J Cereb Blood Flow Metab (2011) 0.95

Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats. Neuropharmacology (2015) 0.92

Manipulation of adenosine kinase affects sleep regulation in mice. J Neurosci (2010) 0.91

Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options. J Inherit Metab Dis (2015) 0.90

Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics (2010) 0.90

Caffeine prevents acute mortality after TBI in rats without increased morbidity. Exp Neurol (2011) 0.89

Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. Mol Metab (2014) 0.89

Adenosine dysfunction and adenosine kinase in epileptogenesis. Open Neurosci J (2010) 0.88

Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR. Hepatology (2012) 0.88

An Adenosine-Mediated Glial-Neuronal Circuit for Homeostatic Sleep. J Neurosci (2016) 0.87

Role of adenosine in status epilepticus: a potential new target? Epilepsia (2013) 0.84

Modulators of nucleoside metabolism in the therapy of brain diseases. Curr Top Med Chem (2011) 0.83

The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine. Front Mol Neurosci (2016) 0.82

Homeostatic control of brain function - new approaches to understand epileptogenesis. Front Cell Neurosci (2013) 0.81

Comorbidities in Neurology: Is adenosine the common link? Neuropharmacology (2015) 0.80

From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy. Epilepsia (2016) 0.79

Adenosinergic signaling in epilepsy. Neuropharmacology (2015) 0.78

Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery. Seizure (2010) 0.78

Molecular characterization of Chinese hamster cells mutants affected in adenosine kinase and showing novel genetic and biochemical characteristics. BMC Biochem (2011) 0.77

ChIP-seq in steatohepatitis and normal liver tissue identifies candidate disease mechanisms related to progression to cancer. BMC Med Genomics (2013) 0.77

A Breather for SUDEP. Epilepsy Curr (2012) 0.76

Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death. Open Drug Discov J (2010) 0.76

South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase. J Med Chem (2016) 0.76

MRI and (1)H-MRS in adenosine kinase deficiency. Neuroradiology (2016) 0.76

Molecular Differences in Hepatic Metabolism between AA Broiler and Big Bone Chickens: A Proteomic Study. PLoS One (2016) 0.75

Adenosine kinase deficiency with neurodevelopemental delay and recurrent hepatic dysfunction: A case report. Adv Rare Dis (2016) 0.75

Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity. J Neurosci (2016) 0.75

Adenosine-associated delivery systems. J Drug Target (2015) 0.75

Dynamic Regulation of the Adenosine Kinase Gene during Early Postnatal Brain Development and Maturation. Front Mol Neurosci (2016) 0.75

Aberrant activation of the human sex-determining gene in early embryonic development results in postnatal growth retardation and lethality in mice. Sci Rep (2017) 0.75

Drosophila imaginal disc growth factor 2 is a trophic factor involved in energy balance, detoxification, and innate immunity. Sci Rep (2017) 0.75

Genetic Disruption of Adenosine Kinase in Mouse Pancreatic β-Cells Protects Against High Fat Diet-Induced Glucose Intolerance. Diabetes (2017) 0.75

Profound hypothermia after adenosine kinase inhibition in A1AR-deficient mice suggests a receptor-independent effect of intracellular adenosine. Pflugers Arch (2016) 0.75

Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies. J Clin Invest (2017) 0.75

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell (1991) 14.89

Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 9.19

Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet (1997) 5.13

Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A (1995) 3.51

The metabolism of homocysteine: pathways and regulation. Eur J Pediatr (1998) 2.11

Hepatic steatosis: innocent bystander or guilty party? Hepatology (1998) 1.94

Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr (1998) 1.81

Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine. J Biol Chem (1979) 1.73

Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc Natl Acad Sci U S A (1995) 1.54

Structure of human adenosine kinase at 1.5 A resolution. Biochemistry (1998) 1.52

Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc Natl Acad Sci U S A (1983) 1.52

Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem (1986) 1.47

Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase. Proc Natl Acad Sci U S A (1997) 1.44

Rapid amplification of a retrotransposon subfamily is evolving the mouse genome. Nat Genet (1998) 1.44

Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol (1998) 1.39

Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem (1998) 1.37

Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr (1997) 1.32

Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nat Genet (1995) 1.27

Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol (1997) 1.18

Adenosine analogues as substrates and inhibitors of S-adenosylhomocysteine hydrolase. Biochemistry (1981) 1.12

Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology (2000) 1.08

Tissue-specific rescue suggests that placental adenosine deaminase is important for fetal development in mice. J Biol Chem (1995) 1.02

Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol (1997) 0.98

Purification and properties of human placental adenosine kinase. J Biol Chem (1979) 0.98

The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine. J Biol Chem (1993) 0.97

LINE-1 (L1) lineages in the mouse. Mol Biol Evol (2000) 0.95

Mechanisms of elevation of adenosine levels in anoxic hepatocytes. Biochem J (1993) 0.95

Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? Nephrol Dial Transplant (1998) 0.94

Developmental expression of adenosine deaminase in the upper alimentary tract of mice. Differentiation (1990) 0.91

Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention. Pharmacol Ther (1993) 0.89

Adenosine kinase inhibitors. Curr Pharm Des (1998) 0.88

Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem Biophys Res Commun (1997) 0.87

Effect of adenosine metabolites on methyltransferase reactions in isolated rat livers. Biochim Biophys Acta (1981) 0.87

Kinetic considerations for the regulation of adenosine and deoxyadenosine metabolism in mouse and human tissues based on a thymocyte model. Biochim Biophys Acta (1982) 0.87

Defects in activation and transport of fatty acids. J Inherit Metab Dis (1999) 0.87

Phosphorylation of adenosine in anoxic hepatocytes by an exchange reaction catalysed by adenosine kinase. Biochem J (1993) 0.87

Fatal neonatal heptic steatosis: a new familial disorder. J Pediatr (1969) 0.81

Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science (2003) 4.57

Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med (2005) 4.42

Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet (2005) 4.21

IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol (2011) 4.18

ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med (2011) 3.96

An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science (2005) 3.61

Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet (2006) 3.12

Bi-directional interconversion of brite and white adipocytes. Nat Cell Biol (2013) 3.08

The TOR-controlled transcription activators GLN3, RTG1, and RTG3 are regulated in response to intracellular levels of glutamine. Proc Natl Acad Sci U S A (2002) 2.87

Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science (2004) 2.82

Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ (2013) 2.74

Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron (2007) 2.58

Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis (2013) 2.38

Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat (2009) 2.34

Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature (2003) 2.31

Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J (2007) 2.27

Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci (2004) 2.25

Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun. Nat Neurosci (2010) 2.23

The gamma 2 subunit of GABA(A) receptors is required for maintenance of receptors at mature synapses. Mol Cell Neurosci (2003) 2.18

Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol (2004) 2.15

De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A (2008) 2.10

Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet (2004) 1.96

Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain (2013) 1.93

Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity (2013) 1.89

Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment. Eur Urol (2008) 1.73

Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis (2014) 1.73

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A (2008) 1.71

Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J (2009) 1.66

PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development (2002) 1.64

Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord (2010) 1.56

Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism. Nat Genet (2009) 1.55

The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells. Proc Natl Acad Sci U S A (2008) 1.54

Comparison of a new self-gripping mesh with other fixation methods for laparoscopic hernia repair in a rat model. J Am Coll Surg (2009) 1.53

Parthenogenetic embryo-like structures in the human ovarian surface epithelium cell culture in postmenopausal women with no naturally present follicles and oocytes. Stem Cells Dev (2009) 1.52

Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain (2005) 1.51

A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood (2010) 1.50

Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS Pathog (2009) 1.50

Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med (2008) 1.46

Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors. Brain (2011) 1.45

Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res (2007) 1.44

Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology (2012) 1.43

Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem (2005) 1.42

High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain (2010) 1.42

GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. J Neurosci (2007) 1.41

Radiographic predictors of visual outcome in orbital compartment syndrome. Ophthal Plast Reconstr Surg (2012) 1.39

Atypical scrapie prions from sheep and lack of disease in transgenic mice overexpressing human prion protein. Emerg Infect Dis (2013) 1.38

Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A (2008) 1.37

Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum Mol Genet (2010) 1.35

Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain (2006) 1.34

Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Mol Cell Neurosci (2003) 1.32

Mitochondria and quality control defects in a mouse model of Gaucher disease--links to Parkinson's disease. Cell Metab (2013) 1.32

The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis. J Biol Chem (2004) 1.30

Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism. Nat Genet (2012) 1.26

Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci (2004) 1.25

Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J Gen Virol (2004) 1.23

Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J Neurosci (2006) 1.23

Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation. Mol Syst Biol (2011) 1.23

Absence of the prion protein homologue Doppel causes male sterility. EMBO J (2002) 1.23

An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis Model Mech (2009) 1.22

Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A (2006) 1.22

DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med (2003) 1.22

Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis. Am J Pathol (2006) 1.20

An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1. Am J Hum Genet (2013) 1.20

Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein. J Gen Virol (2010) 1.19

Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell (2004) 1.18

White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology (2013) 1.18

The changing landscape of genetic testing and its impact on clinical and laboratory services and research in Europe. Eur J Hum Genet (2012) 1.18

MicroRNA-7a regulates pancreatic β cell function. J Clin Invest (2014) 1.18

Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog (2011) 1.17

Synaptic destabilization by neuronal Nogo-A. Brain Cell Biol (2007) 1.17

Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol (2009) 1.16

Coincident pre- and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell (2009) 1.15

An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol (2005) 1.14

Cardiac-specific overexpression of perilipin 5 provokes severe cardiac steatosis via the formation of a lipolytic barrier. J Lipid Res (2013) 1.13

The comprehensive native interactome of a fully functional tagged prion protein. PLoS One (2009) 1.13

One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol (2011) 1.13

Molecular diagnosis of human prion disease. Methods Mol Biol (2008) 1.12

Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy. Am J Med Genet (2002) 1.11

A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philos Trans R Soc Lond B Biol Sci (2008) 1.10

Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell (2003) 1.10

ERK activation causes epilepsy by stimulating NMDA receptor activity. EMBO J (2007) 1.10

NPR1 kinase and RSP5-BUL1/2 ubiquitin ligase control GLN3-dependent transcription in Saccharomyces cerevisiae. J Biol Chem (2004) 1.10

Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neurosci Lett (2005) 1.09

Type I IFN are host modulators of strain-specific Listeria monocytogenes virulence. Cell Microbiol (2007) 1.09

Neurotrypsin cleaves agrin locally at the synapse. FASEB J (2008) 1.09

Rb and p107 are required for normal cerebellar development and granule cell survival but not for Purkinje cell persistence. Development (2003) 1.07

Analysis of the presence and abundance of GABAA receptors containing two different types of alpha subunits in murine brain using point-mutated alpha subunits. J Biol Chem (2004) 1.07

Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis (2013) 1.07

Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits. FASEB J (2012) 1.07

Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy. J Neurol Neurosurg Psychiatry (2013) 1.06

Mutation and biochemical analysis of 19 probands with mut0 and 13 with mut- methylmalonic aciduria: identification of seven novel mutations. Mol Genet Metab (2006) 1.05

Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL. J Immunol (2009) 1.05

Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liver. FASEB J (2004) 1.04

Intrinsic resistance of oligodendrocytes to prion infection. J Neurosci (2004) 1.04

Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother (2009) 1.03

Genome-wide gene expression analysis supports a developmental model of low temperature tolerance gene regulation in wheat (Triticum aestivum L.). BMC Genomics (2011) 1.03

Brain biopsy in dementia: clinical indications and diagnostic approach. Acta Neuropathol (2010) 1.03

Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett (2004) 1.02

Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. BMC Dev Biol (2008) 1.02